Comparing the Efficacy and Safety of Roux-en-Y Gastric Bypass with One-Anastomosis Gastric Bypass with a Biliopancreatic Limb of 200 or 160 cm: 1-Year Results of the Tehran Obesity Treatment Study (TOTS)
- PMID: 32405910
- DOI: 10.1007/s11695-020-04681-3
Comparing the Efficacy and Safety of Roux-en-Y Gastric Bypass with One-Anastomosis Gastric Bypass with a Biliopancreatic Limb of 200 or 160 cm: 1-Year Results of the Tehran Obesity Treatment Study (TOTS)
Abstract
Purpose: One-anastomosis gastric bypass (OAGB) has raised concerns about nutritional complications possibly attributed to the biliopancreatic limb (BPL) length. We aimed to assess the results of a conservative approach of OAGB compared with the original OAGB and Roux-en-Y gastric bypass (RYGB) in a 1-year follow-up study.
Materials and methods: This retrospective study was conducted based on prospectively maintained data in a cohort of patients who underwent either RYGB with a Roux limb of a 150 cm and a BPL of 50 cm (n = 145), OAGB with a 200-cm BPL (n = 272), or OAGB with a 160-cm BPL (n = 383), from March 2013 to 2017 at three university hospitals by a single surgical team.
Results: Groups were comparable regarding age and sex. Mean preoperative body mass indexes of the RYGB, OAGB-160, and OAGB-200 groups were 44.5 ± 5.8, 45.6 ± 6.3, and 46.7 ± 6.4 kg/m2, respectively. One-year follow-up rates were 83.4%, 85.3%, and 82.5% for the RYGB, OAGB-200, and OAGB-160 groups, respectively. One-year percent total weight loss values were 33.8 ± 6.7 after OAGB-160 and 35.3 ± 6.9 after OAGB-200 (P = 0.056), which were significantly greater compared with 30.9 ± 8.9 after RYGB (P < 0.001). All groups were comparable regarding remission of type 2 diabetes mellitus, hypertension, dyslipidemia, and fatty liver. Mean operative time was longer with RYGB than with either OAGB techniques. Groups were comparable for postoperative complications except for the incidence of protein-calorie malnutrition (PCM), occurring in 11 patients (4.7%) after OAGB-200, 7 of whom required revisional surgery, in one patient (0.3%) after OAGB-160 who responded to parenteral alimentation, but in no patients after RYGB.
Conclusion: After 1 year, OAGB with a 160-cm BPL was as effective as OAGB with a 200-cm BPL and RYGB, but safer than OAGB-200. This approach also avoided the need for revisional surgery following postoperative malnutrition.
Keywords: Biliopancreatic limb length; Complication; Effectiveness; One-anastomosis gastric bypass; Roux-en-Y gastric bypass; Safety.
Similar articles
-
Long Biliopancreatic Limb Roux-En-Y Gastric Bypass Versus One-Anastomosis Gastric Bypass: a Randomized Controlled Study.Obes Surg. 2023 Jul;33(7):1966-1973. doi: 10.1007/s11695-023-06631-1. Epub 2023 May 13. Obes Surg. 2023. PMID: 37178225 Free PMC article. Clinical Trial.
-
MGB-OAGB: Effect of Biliopancreatic Limb Length on Nutritional Deficiency, Weight Loss, and Comorbidity Resolution.Obes Surg. 2018 Nov;28(11):3439-3445. doi: 10.1007/s11695-018-3405-7. Obes Surg. 2018. PMID: 30032419
-
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.Lancet. 2019 Mar 30;393(10178):1299-1309. doi: 10.1016/S0140-6736(19)30475-1. Epub 2019 Mar 6. Lancet. 2019. PMID: 30851879 Clinical Trial.
-
One Anastomosis Gastric Bypass Versus Roux-en-Y Gastric Bypass for Obesity: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.Obes Surg. 2020 Apr;30(4):1211-1218. doi: 10.1007/s11695-019-04288-3. Obes Surg. 2020. PMID: 31749109
-
Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies.Obes Surg. 2019 Sep;29(9):3047-3053. doi: 10.1007/s11695-019-04065-2. Obes Surg. 2019. PMID: 31290104 Review.
Cited by
-
Legacy of the Tehran Obesity Treatment Study: Findings from 10 Years Bariatric Surgery Survey.Int J Endocrinol Metab. 2024 Oct 29;22(4):e151608. doi: 10.5812/ijem-151608. eCollection 2024 Oct. Int J Endocrinol Metab. 2024. PMID: 40071051 Free PMC article. Review.
-
Impact of bypass percentage on clinical outcomes following one-anastomosis gastric bypass: a one-year follow-up study.BMC Surg. 2025 Aug 19;25(1):375. doi: 10.1186/s12893-025-03119-w. BMC Surg. 2025. PMID: 40826045 Free PMC article.
-
What Is the Efficacy of Short Length of Biliopancreatic Limb in One-Anastomosis Gastric Bypass? A Systematic Review and Meta-analysis of Short-Term Results.Obes Surg. 2022 Jul;32(7):1-9. doi: 10.1007/s11695-022-06048-2. Epub 2022 Apr 24. Obes Surg. 2022. PMID: 35461404
-
Metabolic-Associated Fatty Liver Disease and Weight Loss After Bariatric Surgery: A Systematic Review and Meta-Analysis.Obes Surg. 2024 Dec;34(12):4459-4471. doi: 10.1007/s11695-024-07585-8. Epub 2024 Nov 19. Obes Surg. 2024. PMID: 39560894 Free PMC article.
-
Nutritional Status after Roux-En-Y (Rygb) and One Anastomosis Gastric Bypass (Oagb) at 6-Month Follow-Up: A Comparative Study.Nutrients. 2022 Jul 9;14(14):2823. doi: 10.3390/nu14142823. Nutrients. 2022. PMID: 35889780 Free PMC article.
References
-
- Collaboration NRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96. - DOI
-
- Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. - DOI
-
- Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94. - DOI
-
- Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019:1–10.
-
- Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials